IL17A and hypertensive disorder: Previous studies have demonstrated that IL-17A can directly induce hypertension associated to endothelial dysfunction, as observed in transgenic mice overexpressing IL-17A in keratinocytes (Karbach et al., 2014), or by intraperitoneal administration of high doses of recombinant IL-17A (Nguyen et al., 2013).